Eli Lilly & Co (LLY) - Oncology Revenue (I:ELCLLYOR)
6.658B USD for 2023
Level Chart
Basic Info
|
Eli Lilly & Co (LLY) - Oncology Revenue is at a current level of 6.658B, up from 5.666B one year ago. This is a change of 17.51% from one year ago. |
|
Oncology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to oncology within a specific reporting period. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 6.658B |
| Latest Period | 2023 |
| Last Updated | Feb 15 2024, 08:41 EST |
| Next Release | Feb 15 2025, 08:30 EST (E) |
| Average Growth Rate | 6.80% |
| Value from 1 Year Ago | 5.666B |
| Change from 1 Year Ago | 17.51% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.658B |
| December 31, 2022 | 5.666B |
| December 31, 2021 | 5.741B |
| December 31, 2020 | 5.319B |
| December 31, 2019 | 4.614B |
| December 31, 2018 | 4.260B |
| Date | Value |
|---|---|
| December 31, 2017 | 3.812B |
| December 31, 2016 | 3.722B |
| December 31, 2015 | 3.510B |
| December 31, 2014 | 3.393B |
| December 31, 2013 | 3.268B |
| December 31, 2012 | 3.282B |
Basic Info
|
Eli Lilly & Co (LLY) - Oncology Revenue is at a current level of 6.658B, up from 5.666B one year ago. This is a change of 17.51% from one year ago. |
|
Oncology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to oncology within a specific reporting period. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 6.658B |
| Latest Period | 2023 |
| Last Updated | Feb 15 2024, 08:41 EST |
| Next Release | Feb 15 2025, 08:30 EST (E) |
| Average Growth Rate | 6.80% |
| Value from 1 Year Ago | 5.666B |
| Change from 1 Year Ago | 17.51% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |